Solid Biosciences logo

Director, Trial Master File (TMF)

Solid Biosciences

Charlestown, MA; Any City, USHybridPosted 1 day ago$220,000 - $250,000/year
Full TimeDirector & AboveClinical DevelopmentBiotechnology
Original posting ↗

Summary

Solid Biosciences is a precision genetic medicine company focused on advancing a portfolio of gene therapy candidates targeting rare neuromuscular and cardiac diseases. We are seeking a Director, Trial Master File (TMF) to lead the strategy, governance, establishment, and day-to-day oversight of the Trial Master File (TMF) across all assigned clinical trials and programs, ensuring each TMF is complete, accurate, contemporaneous, and inspection-ready at all times.

Job description

Key Position Responsibilities

  • Define and implement the TMF strategy, governance model, and TMF Plans for all clinical programs in coordination with the Clinical Operations Lead.
  • Ensure TMF content and processes comply with ICH GCP, the DIA TMF Reference Model, health authority regulations (e.g., FDA, EMA), and company SOPs.
  • Own the eTMF system, including vendor selection, configuration, validation, user access, and ongoing system performance.
  • Oversee CRO and vendor TMF activities; set expectations, metrics, and oversight plans, and propose TMF vendors to senior management for approval.
  • Establish and monitor TMF quality and completeness metrics (timeliness, completeness, and quality KPIs); lead ongoing TMF reviews and drive corrective and preventive actions.
  • Ensure continuous inspection readiness; lead TMF preparation, support, and responses for audits and regulatory inspections.
  • Develop, review, and maintain TMF-related SOPs, work instructions, templates, and training materials, including new-hire and refresher training for study teams and CROs.
  • Manage TMF reconciliation and transfer activities, including study start-up, ongoing maintenance, close-out, archiving, and sponsor/CRO TMF transitions.
  • Collaborate with cross-functional study teams to support timely filing of essential documents and achievement of clinical trial deliverables.
  • Identify and resolve key cross-functional, sponsor-site, and sponsor-CRO TMF issues and escalate risks as appropriate.
  • Manage the TMF function budget, resources, and timelines.

Experience Requirements

  • BA/BS (preferably in a life science or healthcare field); Master's degree preferred in a scientific or healthcare discipline.
  • Minimum of 8 years in clinical and drug development in the pharmaceutical/biotech industry, with progressive experience in TMF management and clinical operations for complex clinical trials.
  • Thorough understanding of ICH GCP, FDA and country-specific regulations, the DIA TMF Reference Model, and eTMF systems, as well as cross-functional clinical processes including quality assurance, regulatory affairs, and data management.
  • Demonstrated experience supporting regulatory inspections and audits.
  • Understanding of drug development from pre-IND through BLA.
  • Ability to manage and operationalize a high volume of detailed tasks within a given timeline.
  • Ability to lead a cross-functional team in a matrix environment.
  • Ability to take a leadership role, motivate staff, and drive high-quality execution.
  • Excellent interpersonal and negotiation skills, including vendor and CRO management.
  • Excellent verbal and written communication and presentation skills.
  • Demonstrated planning and project management skills, including risk assessment, contingency planning, and prioritization.
  • Meticulous attention to detail with a strong quality and compliance mindset.
  • Ability and willingness to travel up to 10% of the time (international and domestic).

Requirements

  • BA/BS preferably in a life science or healthcare field
  • Master's degree preferred in a scientific or healthcare discipline
  • Minimum of 8 years in clinical and drug development in the pharmaceutical/biotech industry
  • Progressive experience in TMF management and clinical operations for complex clinical trials
  • Thorough understanding of ICH GCP, FDA and country-specific regulations
  • Knowledge of the DIA TMF Reference Model and eTMF systems
  • Understanding of cross-functional clinical processes including quality assurance, regulatory affairs, and data management
  • Demonstrated experience supporting regulatory inspections and audits
  • Understanding of drug development from pre-IND through BLA
  • Ability to manage and operationalize a high volume of detailed tasks within a given timeline
  • Ability to lead a cross-functional team in a matrix environment
  • Ability to take a leadership role, motivate staff, and drive high-quality execution
  • Excellent interpersonal and negotiation skills, including vendor and CRO management
  • Excellent verbal and written communication and presentation skills
  • Demonstrated planning and project management skills, including risk assessment, contingency planning, and prioritization
  • Meticulous attention to detail with a strong quality and compliance mindset
  • Ability and willingness to travel up to 10% of the time

Benefits

  • Health & Dental Insurance
  • FSA & HSA
  • 401(k) Matching
  • Employee Stock Purchase Plan
  • Mobile Phone Subsidy
  • Tuition Reimbursement
  • Vision Coverage
  • Life Insurance
  • Voluntary Pet Insurance
  • Employee Discount Program
  • Employee Assistance Programs
  • Subsidized Lunch Delivery
  • Free Onsite Gym
  • Employee Parking
  • 12 Observed Holidays
  • Winter Shutdown
  • 15-day PTO
  • 40-hour Sick Policy
  • 8-hour Floating Holiday

Company overview

Solid Biosciences is a precision genetic medicine company focused on developing innovative gene therapies for rare neuromuscular and cardiac diseases. Founded in 2013 and headquartered in Charlestown, Massachusetts, the company has established itself as a leader in the biotechnology research sector with approximately 148 employees. Solid Biosciences' pipeline includes several promising gene therapy candidates targeting devastating conditions such as Duchenne muscular dystrophy (SGT-003), Friedreich's ataxia (SGT-212), catecholaminergic polymorphic ventricular tachycardia (SGT-501), and TNNT2-mediated dilated cardiomyopathy (SGT-601). The company employs a patient-focused approach, having been founded by individuals directly impacted by Duchenne muscular dystrophy, which drives their mission to improve the daily lives of patients living with rare genetic diseases. Beyond therapeutic development, Solid Biosciences is advancing innovative libraries of genetic regulators and enabling technologies designed to significantly impact gene therapy delivery across the industry. The company has raised substantial funding, including a recent $240 million private placement, and trades publicly on the NASDAQ under the symbol SLDB. Their research focuses on uniting experts in science, technology, disease management, and care to develop transformative precision genetic medicines.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.